A weekly review of the Market Timing signals with Market Commentary and Technical Analysis.
In this week's #AskAlan Facebook Livestream, we discuss the difference between LIC's and managed funds, ETF's, the lithium play, the Aussie dollar and a whole lot more.
September 20, 2018
Dr Bill Ketelbey is the CEO of Actinogen Medical. They’re in the middle of phase two trials for an Alzheimer’s drug called Xanamem. Alan Kohler spoke to Bill to find out more about it.
September 19, 2018
This week's Fund Manager interview is with Kevin Hua, the Founder and Head of Investments for AtlasTrend. It's a Sydney based business that invests globally in themes, and they've got four themes at the moment: Big Data, Clean Disruption, Online Shopping Sprees and Splurging Baby Boomers. Alan Kohler spoke to Kevin to find out how it all works.
In this week's edition of Investment Ideas, Charles Leyland, Managing Director of Leyland Private Asset Management analyses three stocks he's currently following from a diverse range of sectors.
September 18, 2018